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Objective: This study was undertaken to describe the technique of transfemoral superselective coil embolization of type II
endoleak and its influence on abdominal aortic aneurysm diameter.
Methods: Over 23 months, 104 aortic stent grafts were deployed to exclude abdominal aortic aneurysms, at an academic
medical center. Increase in aneurysm diameter and perigraft findings on contrast material–enhanced computed tomog-
raphy scans prompted arteriography. Procedures were performed solely by vascular surgeons in a surgical angiography
suite. In 7 patients aneurysm access was via the iliolumbar branches of the internal iliac artery, and in 1 patient aneurysm
access was via the inferior mesenteric artery through the arc of Riolan from the superior mesenteric artery. Coaxial
catheters were placed to gain access to the aneurysm (8F to 5F to 3F, or 5F to 3F). A 3F Tracker18 was the most distal
catheter through which an assortment of 0.018 microcoils were deployed within the aneurysm, and the origin of the
feeding vessels when possible.
Results: Aneurysm diameter increased 0.48  0.2 cm over 10.8  5 months before superselective coil embolization. In 6
of 8 patients superselective coil embolization embolization resulted in a mean decrease in aneurysm diameter of 1.3 1.2
cm over 9 3.2 months. Failure was presumed due to inability to reach the aneurysm sac in 1 patient and was associated
with oral anticoagulation in 1 other patient.
Conclusion: Proper identification of the source of type II endoleak and its complete occlusion, combined with aneurysm
sac coiling, may result in prompt decrease in aneurysm size. (J Vasc Surg 2003;38:61-6.)
Encouraged by favorable early results of aortic en-
dograft to treat infrarenal abdominal aortic aneurysm, this
procedure has continued to gain popularity. The primary
goal of therapy is to prevent aneurysm rupture. Increase in
aneurysm diameter or volume is considered failure of ther-
apy, and often secondary interventions are necessary to
address the cause of aneurysm enlargement.1,2 Various
mechanisms of device failure have been reported, resulting
in persistent pressurization of the aneurysm sac.3-6 This
may be noted at radiography as contrast blush within the
aneurysm, either on computed tomography (CT) scans or
diagnostic angiograms. The term endoleak was coined to
describe this condition.1,7 Type II endoleak is the most
common form and results from retrograde filling of the
aneurysm from the lumbar, inferior mesenteric, accessory
renal, or sacral arteries.8 The significance and natural his-
tory of type II endoleak has not been completely defined.9
However, reports of aneurysm rupture after persistent type
II endoleak has been described.10,11
We report our experience with superselective coil em-
bolization performed to treat type II endoleak.
PATIENTS AND METHODS
Over 23 months, 104 aortic stent grafts (AneuRx,
Medtronic/AVE, Santa Rosa, Calif; Ancure, Guidant, In-
dianapolis, Ind) were deployed to exclude abdominal aortic
aneurysm, at an academic medical center. No patients were
discharged to home with type I endoleak. All patients
underwent follow-up CT at 6-month intervals. Eight pa-
tients with type II endoleak apparent on 6-month fol-
low-up CT scans underwent aortography. All 8 patients
were men, with mean age of 68.9  7 years and mean
preinterventional aneurysm diameter of 6.5  1.3 cm.
Increased aneurysm diameter (0.48  0.2 cm over 10.8 
5 months) was noted on CT scans in 5 of 8 patients, with
obvious contrast blush seen along the periphery of the
aneurysm sac, suggestive of type II endoleak. All 8 patients
were offered angiography to identify and possibly treat the
endoleak, because it was our policy to aggressively investi-
gate and treat all type II endoleak with or without change in
aneurysm sac diameter. One patient was receiving warfarin
sodium anticoagulation therapy because of chronic atrial
fibrillation. For initial aneurysm exclusion, an AneuRx en-
dograft was used in 6 patients and an Ancure graft was used
in 2 patients. In 2 patients, both with AneuRx grafts, an
initial decrease in diameter after endograft placement was
followed by an increase in aneurysm diameter, and a new-
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onset type II endoleak was seen on CT scans. In 1 of these
patients the aneurysm sac had decreased from 4.8 cm to 4
cm over 6 months, then increased to 4.7 over the next 12
months. In the other patient the aneurysm sac had de-
creased from 6 cm to 4.5 cm, and subsequently increased to
6 cm over 8 months.
Technique of superselective coil embolization. Per-
cutaneous femoral access was used in all patients. In 2
patients in whom the stent graft was extended to the
external iliac artery the contralateral femoral artery was used
for access, to have access to the ipsilateral internal iliac
artery should this prove to be the site of origin of the type II
endoleak. Initial angiography was performed through a
diagnostic pigtail catheter positioned above the endograft
at the level of the renal arteries, with 8 mL of contrast
material per second, to a total of 35 mL. Prolonged run
times were used to enable visualization of any delayed
filling of the aneurysm sac. Then additional contrast mate-
rial was injected, ie, 5 mL/s to a total of 25 mL, with the
diagnostic catheters in the iliac limbs. If the vessel feeding
the aneurysm was not yet visualized, selective cannulation
of the internal iliac artery followed by selective cannulation
of the superior mesenteric artery was performed. Bilateral
femoral artery access was obtained if necessary, and was
required in 4 patients because the initial entry site was the
right common femoral artery and the endoleak was noted
to arise from the left internal iliac artery. All type II en-
doleaks from the iliolumbar arteries were branches of the
left internal iliac artery, and all entry sites were on the left of
the aneurysm at L3-L4. All patients received systemic anti-
coagulation with heparin, as is our practice in all superse-
lective catheterization techniques.
In 7 patients the aneurysm sac was found to fill from
branches of the left internal iliac artery. An ipsilateral fem-
oral approach was used in all 7 patients. Selective cannula-
tion of the origin of the internal iliac artery was performed
with a 5F right internal mammary artery catheter or Sos
catheter (both from Cook Inc, Bloomington, Ind). With a
road-mapping technique, selective cannulation of the vessel
supplying the iliolumbar arteries, responsible for the type II
endoleak, was performed with an angled 0.035 glide wire
(Boston Scientific/Target, Natick, Mass) through the right
internal mammary artery or Sos catheter positioned at the
origin of the internal iliac artery. Subsequently, the catheter
was withdrawn and exchanged for an angled glide catheter
(Boston Scientific/Target) over the 0.035 glide wire, and
this catheter was passed as far up the iliolumbar arteries as
technically feasible. Then the glide wire was withdrawn,
and a 3F catheter with an 0.018 guide wire (Tracker18
catheter; Boston Scientific/Target) was coaxially passed
through the 5F angled glide catheter toward the aneurysm
sac. Road-mapping was liberally used to guide catheter
placement along the way.
In two patients the vessel supplying the iliolumbar
arteries originated from the internal iliac artery, and
branched off immediately after the internal iliac artery
takeoff. Selective cannulation of this branch was technically
impossible because the catheter tended to easily flip out of
the internal iliac artery. Instead of attempting a transbra-
chial approach, we placed a 7F or 8F Balkan sheath (Cook
Inc) at the origin of the internal iliac artery and held it in
place with a Rosen wire (Boston Scientific) extending into
the distal internal iliac artery (Fig 1, A). In both patients the
Balkan sheath was introduced from the ipsilateral femoral
access site (Fig 1, A-C). The glide catheter and the Track-
er18 were subsequently passed along the side of the Rosen
wire through the Balkan sheath (Fig 1, A-C). A 7F or 8F
Balkan sheath was required because the Rosen wire was left
in place and the 5F angled glide catheter was inserted
alongside this wire (Fig 1, B); a smaller caliber Balkan
sheath would have required withdrawal of the Rosen wire,
thereby losing the additional support in the internal iliac
artery that was provided by this “buddy wire” technique.
Once access to the aneurysm sac was gained, the 3F cathe-
ter was manipulated through the aneurysm to cannulate the
outflow branch. An assortment of microcoils were used to
embolize the outflow vessel, aneurysm sac, and inflow
vessels. For the sake of description, the artery accessed to
cannulate the aneurysm sac is referred to as “inflow,” and
arterial branches noted with injection of contrast medium
into the aneurysm sac are referred to as “outflow.” An
attempt was always made to coil the outflow vessels and
aneurysm sac (Fig 2, A and B).
In 2 patients we were unable to reach the aneurysm sac
because of a large number of extremely small and tortuous
source vessels. A liquid embolic agent (D-Stat; Vascular
Solutions Inc, Minneapolis, Minn) was used to thrombose
these multiple feeding vessels, in addition to coil emboliza-
tion (Fig 3, A and B). D-Stat, a mixture of thrombin and
collagen, was used because it was readily available in the
Duett (Vascular Solutions Inc) femoral closure device pack-
age. Thrombus formation requires interaction with blood,
and hence this had the advantage of not occluding the
Tracker18 catheter, which could be left in place for subse-
quent contrast material injection and additional interven-
tions. Plain thrombin was not used, because it is highly fluid
and hence has the propensity to diffuse farther away from
the target site.
In 1 patient the aneurysm was fed from the inferior
mesenteric artery via the meandering mesenteric artery (Arc
of Riolan) from the superior mesenteric artery. Selective
transfemoral cannulation of the superior mesenteric artery
was performed with a Cobra 2 catheter (Cook Inc), and
with road-mapping we were able to coaxially pass the 3F
Tracker18 catheter to the aneurysm sac (Fig 4, A). Once
inside the aneurysm sac, the outflow lumbar artery was
identified and cannulated. Coil embolization was per-
formed on the outflow lumbar artery, aneurysm sac, and
inferior mesenteric artery inflow to the aneurysm sac. Care
was taken not to place coils in the meandering mesenteric
artery, to prevent ischemic complications to the colon (Fig
4, B).
RESULTS
The lumbar artery or the inferior mesenteric artery
feeding the aneurysm sac was identified in all 8 patients.
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Access to the aneurysm sac was achieved in 6 of 8 patients.
In the 2 patients in whom we were unable to reach the
aneurysm sac (retiform anastomosis) the feeding vessels
were coiled and then injected with a mixture of collagen
and thrombin (D-Stat). Thrombosis of all feeding vessels
was angiographically visualized after injection of the liquid
embolic agent; however, in these 2 patients coiling of the
actual aneurysm sac was not possible. On the basis of initial
angiographic appearance, no filling of the aneurysm sac was
noted in any patients at completion of the coiling proce-
dure.
After superselective coil embolization, the aneurysm
sac demonstrated reduction of aneurysm diameter in 6 of 8
patients (mean decrease, 1.3  1.2 cm over 9  3.2
months). In 1e patient receiving warfarin sodium anticoag-
ulation therapy the aneurysm continued to fill with a small
type II endoleak through the coils deployed in the previous
intervention. Warfarin anticoagulation was discontinued,
but endoleak persisted at the site of coil embolization. The
patient has refused further therapy, because of advanced
age and debilitated status. The last CT scan obtained
demonstrated a 4 mm increase in aneurysm diameter.
Fig 1. A, Technique of transfemoral cannulation of proximal
internal iliac artery branch. Internal iliac access maintained with 7F
Balkan sheath held in place with a Rosen wire in the distal internal
iliac. Arrow, Tip of Balkan sheath at origin of internal iliac artery.
B, 5F angled glide wire (arrow at tip) is passed alongside Rosen
wire to cannulate iliolumbar artery. C, Tracker18 (3F; small arrow)
is passed alongside Rosen wire through a 5F angled glide wire
catheter (large arrow).
Fig 2. A, Tracker18 in a feeding vessel. Angiogram demonstrates
type II leak with outflow branches. B, Complete aneurysm and
feeding vessel (arrow) coiling to treat persistent type II endoleak.
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In another patient, in whom we were unable to reach
the aneurysm sac, type II endoleak persists despite liquid
embolization of all feeding lumbar vessels. No increase in
aneurysm diameter was noted at 6-month follow-up, and
the patient has opted for CT follow-up at another 6
months. It could not be ascertained whether the persistent
type II endoleak was from the same source vessel, because
the patient currently refuses further angiographic evalua-
tion.
No major complications have been observed. In the
patient receiving warfarin anticoagulation therapy and with
persistent type II endoleak, severe buttock claudication
developed and had not resolved at 9 months of follow-up.
In this patient the contralateral internal iliac artery was
embolized and the AneuRx stent limb was extended to the
external iliac artery at primary stent graft placement. This
was done to exclude a common iliac aneurysm at endograft
placement. However, the buttock claudication developed
subsequent to coil embolization, on the ipsilateral side,
probably indicating that one of the branch vessels that were
coiled may have been an important collateral vessel to the
gluteal muscles.
DISCUSSION
Transarterial coil embolization to treat type II endoleak
has been performed with varying degrees of success.12-15
Failure was often the result of inability to reach and coil the
aneurysm sac.12,13 In 5 of our 6 patients in whom direct sac
access was possible the endoleak was excluded successfully,
with demonstrable decrease in aneurysm diameter. How-
ever, transarterial coil embolization is not a simple proce-
dure, and requires advanced catheter skill and knowledge of
use of microcatheters. We chose to use coils rather than
liquid embolic agents, because of the propensity of liquid
embolic agents to diffuse into non–target vessels with cat-
astrophic results. Colonic necrosis as a result of mesenteric
thrombosis, and permanent nerve injury have been re-
ported after use of liquid embolic agents.16,17 We chose to
use liquid embolic agents only when attempts to gain access
Fig 3. A, Type II endoleak via numerous small, tortuous lumbar
arteries. Access to sac was not possible, and collateral vessels persist
despite proximal coiling. Arrow, Site of coil placement and persis-
tent flow of contrast material into retiform collateral vessels. B,
Lumbar vessels thrombosed with a combination of liquid embolic
agent and coils Arrow, Site of coil. Note no flow beyond this level.
Fig 4. A, Aneurysm sac access via superior mesenteric artery and
arc of Riolan. Arrows delineate course of Tracker18 catheter in
meandering mesenteric artery. B, Coils in outflow lumbar arteries,
aneurysm, and distal inferior mesenteric artery. Arc of Riolan is
spared to preserve colonic perfusion.
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to the aneurysm sac failed. In 2 patients the liquid embolic
agent was combined with coil embolization to prevent free
diffusion of the liquid agent. In 1 of these patients with a
small type II endoleak we were able to coil the lumbar
arteries leading to and from the aneurysm, and the site of
entry into the aneurysm, and in addition we used D-Stat to
seal the lumbar arteries. However, type II endoleak persists
because direct sac embolization failed. Because this type II
leak is small, we did not believe it would be amenable to
direct translumbar sac puncture. Currently this patient is
being followed up with serial CT. At 6-month follow-up,
CT scans did not demonstrate increase in diameter of the
aneurysm, despite persistent endoleak.
When an aneurysm continues to enlarge after place-
ment of an endograft, the procedure should be considered
failed and further, aggressive investigation should be car-
ried out, with or without evidence of endoleak on CT scans.
However, presence of type II endoleak in aneurysms that
are not expansile or are even decreasing in size has resulted
in varying approaches to treatment. The EUROSTAR ex-
perience did not reveal a higher incidence of aneurysm
rupture in stable aneurysms with type II endoleak (0.52%
rupture incidence) compared with stable aneurysms with
no endoleak (0.25% rupture incidence).18 Although this
did not reach statistical significance, the incidence was
almost two times greater than with aneurysms with no
endoleak, suggesting the possibility of a type II statistical
error. Parry et al17 demonstrated that type II endoleak is
associated with a 2 mm increase in aneurysm diameter,
compared with a 3 mm reduction in aneurysm diameter in
the absence of type II endoleak. Inasmuch as no conclusive
evidence indicates otherwise, it has been our practice to
offer further interventions to treat all type II endoleak that
persists at 6-month follow-up. Because coil embolization is
reported to be safe and effective, we offer this as the first
treatment option. Although liquid embolic agents are less
expensive, complications occur more frequently their
use.16,17 Various other techniques, eg, direct CT-guided
sac puncture and laproscopic ligation of the lumbar arteries,
have been described, but have not gained widespread ac-
ceptance.18-21 It should also be noted that not all experts in
the field are of the opinion that all type II endoleak should
be aggressively treated, reserving therapy only in the event
of nonshrinking or enlarging sac diameter. In a recent
consensus conference, 85% of respondents indicated that
transarterial coil embolization of the aneurysm sac, via the
hypogastric artery or superior mesenteric artery, is their
preferred method for management of type II endoleak.22
In our experience, the main disadvantage of performing
coil embolization to treat type II endoleak is the artifact
that is produced on follow-up CT scans. This artifact often
makes it impossible to detect any contrast material extrav-
asation at the site of the previous endoleak. Hence a de-
crease in the size of the aneurysm sac may be the best, and
only, indicator of successful coil embolization of type II
lumbar endoleak. Although duplex ultrasound scanning
has been used by few authors to follow up and detect
endoleak, we have not had much success with this tech-
nique. This is similar to the consensus of the international
conference: 69% believe duplex ultrasound scanning is not
the best method for detection of endoleak.22
The high late failure rate reported with transarterial coil
embolization of type II endoleak may be explained by
failure to coil the aneurysm sac. Baum et al23 reported a
92% success rate if the sac was directly coiled with translum-
bar puncture; in contrast, an 80% failure rate was noted
with transarterial coil embolization of the feeding vessels.
This model of actual coiling of the aneurysm sac was used in
6 of our patients, the only difference being transarterial
access to the aneurysm sac. Hence, on the basis of the
report by Baum et al23 and our results, we believe isolated
coiling of feeding vessels is predictive of a high failure rate.
This was also noted in a recent publication by the group
from Southern Illinois University who, despite initial an-
giographic appearance of success with coil embolization of
the feeding vessels, reported a 60% failure rate after subse-
quent evaluation of CT scans.24 Despite their attempt to
classify type II endoleak on the basis of complexity of the
feeding vessels, this had no effect on success of treatment,
because direct sac access often was not achieved. On the
basis of our results, our treatment algorithm for type II
endoleak currently involves an initial attempt at transarte-
rial access to the aneurysm sac; if the aneurysm sac cannot
be reached, the patient is referred to a radiologist for
CT-guided translumbar sac puncture.
Various authors have demonstrated the influence of the
number and size of patent aortic branches arising from the
aneurysm and their relationship to occurrence of type II
endoleak.15,17,25,26 Parry et al17 noted no endoleak in the
absence of patent side branches, compared with a 62%
endoleak rate with patent lumbar arteries. However, we
have not attempted preoperative coil embolization of lum-
bar or inferior mesenteric vessels. Gould et al27 reported no
decrease in incidence of type II endoleak after preoperative
embolization, and concluded that this was an ineffective
procedure. The failure of preoperative coiling of branch
vessels may have failed because of inability to identify and
coil all aortic side branches; this form of complex network
of collateral channels has subsequently been clearly demon-
strated.24
The requirement for direct aneuryismal sac thrombosis
with embolic agents may be further substantiated by the
work of Walker et al.28 These authors packed the aneurysm
sac with collagen sponge at primary endografting, which
significantly reduced the incidence of type II endoleak by
achieving complete aneurysm thrombosis, even in patients
with multiple aortic side branches.28,29 However, Marty et
al,30 in experimentally induced aortic aneurysms, failed to
show a reduction in pressure within the aneurysm after
embolization with metal coils used to treat direct antegrade
endoleak. However, no details of the embolization tech-
nique or status of feeding vessels were provided.
Although technically challenging, the ability to per-
form transarterial coil embolization may be readily acquired
by vascular surgeons dedicated to becoming multifaceted
endovascular specialists. To our knowledge, this is the first
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report of superselective coiling of endoleak solely per-
formed by vascular surgeons in a self-contained operating
room angiography suite equipped with a ceiling- mounted
system and a 15-inch image intensifier. The results may also
reflect the superior imaging required for these procedures.
Use of portable C arms for complex time-consuming vas-
cular interventions may fail, not because of technical inabil-
ity but as a result of poor imaging. Although the immediate
results of embolization of type II endoleak are promising,
long-term results with this technique are not known.
Whether long-term reduction in aneurysm sac pressure is
achieved with coil embolization remains unknown.
In conclusion, we believe complete embolization of all
inflow and outflow vessels, combined with embolization of
the aneurysm sac, may provide the most durable treatment
of type II endoleak.
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